FDA Inspection 663664 - Piedmont Reproductive Endocrinology Group, Pa - May 25, 2010
FDA Inspection 663664 for Piedmont Reproductive Endocrinology Group, Pa on May 25, 2010. Classification: No Action Indicated (NAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 663664 for Piedmont Reproductive Endocrinology Group, Pa on May 25, 2010. Classification: No Action Indicated (NAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
May 25, 2010
Product Type
Biologics
ID: fa5e39b9-789d-44c7-a531-273de276986b
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox